Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;98(6):329-331.
doi: 10.1159/000507586. Epub 2020 May 14.

Oncology Informatics: Status Quo and Outlook

Paul Martin Putora  1   2 , Michael Baudis  3 , Beth M Beadle  4 , Issam El Naqa  5 , Frank A Giordano  6 , Nils H Nicolay  7   8
Affiliations
Review

Oncology Informatics: Status Quo and Outlook

Paul Martin Putora et al. Oncology. 2020.

Abstract

Oncology has undergone rapid progress, with emerging developments in areas including cancer stem cells, molecularly targeted therapies, genomic analyses, and individually tailored immunotherapy. These advances have expanded the tools available in the fight against cancer. Some of these have seen broad media coverage resulting in justified public attention. However, these achievements have only been possible due to rapid developments in the expanding field of biomedical informatics and information technology (IT). Artificial intelligence, radiomics, electronic health records, and electronic patient-reported outcome measures (ePROMS) are only a few of the developments enabling further progress in oncology. The promising impact of IT in oncology will only become reality through a multidisciplinary approach to the complex challenges ahead.

Keywords: Artificial intelligence; Cancer; Electronic health record; Electronic patient-reported outcome measures; Informatics; Machine learning; Oncology; Radiation oncology.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement

The authors have no conflicts of interest to declare.

References

    1. Fenn J, Linden A. Understanding Gartner’s hype cycles. Strategic analysis report No. R-20–1971. Gartner, Inc.; 2003. p. 88.
    1. Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017. Jul 11;318(2):197–8.10.1001/jama.2017.7156 - DOI - PMC - PubMed
    1. Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. 2017. Sep 1;109(9).10.1093/jnci/djx029[pubmed match] - DOI - PubMed
    1. Ahlbrandt J, Lablans M, Glocker K, Stahl-Toyota S, Maier-Hein K, Maier-Hein L, et al. Modern information technology for cancer research: What’s in IT for me? An overview of technologies and approaches. Oncology. 2018. Nov 15:1–7. - PubMed
    1. Dubovitskaya A, Novotny P, Xu Z, Wang F. Applications of blockchain technology for data-sharing in oncology: Results from a systematic literature review. Oncology. 2019. Dec:1–9. - PubMed